Literature DB >> 17845455

A critique of the innovation argument against a national health program.

Alex Rajczi1.   

Abstract

President Bush and his Council of Economic Advisors have claimed that the US shouldn't adopt a national health program because doing so would slow innovation in health care. Some have attacked this argument by challenging its moral claim that innovativeness is a good ground for choosing between health care systems. This reply is misguided. If we want to refute the argument from innovation, we have to undercut the premise that seems least controversial--the premise that our current system produces more innovation than a national health program would. I argue that this premise is false. The argument requires clarifying the concept 'national health program' and examining various theories of human well-being.

Entities:  

Mesh:

Year:  2007        PMID: 17845455     DOI: 10.1111/j.1467-8519.2007.00559.x

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  1 in total

1.  Cost-effectiveness sequential modeling of ranibizumab versus usual care in age-related macular degeneration.

Authors:  S Y Cohen; D Bremond-Gignac; G Quentel; G Mimoun; T Citterio; S Bisot-Locard; A Beresniak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-19       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.